IRCT20210531051459N2尚未招募3 期
The effect of quercetin on inflammatory cytokines and clinical signs of patient with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP): The randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
- •Conscious consent to participate in the study
- •Aged 18 years and older
排除标准
- •Pregnancy and lactation
- •Diagnosis of blood diseases and blood cancers such as leukemia
- •Consumption of quercetin in the last three months
- •Crocin supplementation
- •Curcumin supplementation
- •Vitamin C supplementation
- •Dissatisfaction with participating in the study
研究者
相似试验
招募中
不适用
Effect of Quercetin on PCOS patientsPoly Cystic Ovary Syndrome.IRCT20210516051323N1Islamic Azad University42
已完成
不适用
The effect of quercetin on PCOS patientsPolycystic Ovary Syndrome.Sclerocystic ovary syndrome Stein-Leventhal syndromeIRCT2013112515536N1Tehran University of Medical Sciences42
尚未招募
3 期
The effect of quercetin supplement on patients with myocardial infarctiomyocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20090822002365N19Iran University of Medical Sciences88
招募中
1 期
Biological Effects of Quercetin in COPDChronic Obstructive Pulmonary DiseaseNCT03989271Temple University29
已完成
3 期
Quercetin in COVID19COVID19.Corona virus infection, unspecifiedU07.1IRCT20200419047128N2Ahvaz University of Medical Sciences60